Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0178874 (
tumor progression
)
40,807
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. Hydroxysteroid dehydrogenase like 2 (
HSDL2
) can regulate lipid metabolism and take part in cell proliferation. The purpose of the present study was to explore functional role of
HSDL2
gene in PTC. The expression of HSDL2 protein in PTC tissues was estimated using immunohistochemistry analysis (IHC).
HSDL2
mRNA level was detected through quantitative real-time polymerase chain reaction (qRT-PCR). Effects of
HSDL2
gene on cell proliferation and apoptosis were assessed using the shRNA method for both
in vitro
and
in vivo
experiments. Potential target genes of
HSDL2
were determined via bioinformatics analyses and Western blotting.
HSDL2
was up-regulated in PTC tissues and cell lines compared with the controls (all
P
<0.05). Inhibiting HSDL expression could suppress PTC cell proliferation and cycle, and promote apoptosis
in vitro. In vivo
, the knockdown of
HSDL2
gene could significantly suppress tumor growth (all
P
<0.05). Furthermore,
AKT3, NFATc2
and
PPP3CA
genes might be potential targets of
HSDL2
in PTC.
HSDL2
expression was increased in PTC tissues and cells, which could promote
tumor progression
in vitro
and
in vivo
.
...
PMID:Down-regulated
HSDL2
expression suppresses cell proliferation and promotes apoptosis in papillary thyroid carcinoma. 3110 84
Gynecological cancer is the leading cause of cancer mortality in women. However, the mechanisms underlying gynecological
cancer progression
have remained largely unclear. In the present study, 799 dysregulated genes were identified in ovarian serous cystadenocarcinoma (OV), 488 dysregulated genes in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), and 621 dysregulated genes in uterine corpus endometrial carcinoma (UCEC). Bioinformatics analysis revealed that mRNA splicing and cell proliferation-associated biological processes served important roles in OV progression. Metabolism-associated biological processes played important roles in CESC progression, and protein phosphorylation and small GTPase-mediated signal transduction served important roles in UCEC progression. The present study also constructed OV, CESC and UCEC progression-associated protein-protein interaction networks to reveal the associations among these genes. Furthermore, Kaplan-Meier curve analysis showed that progression-related genes were associated with the duration of overall survival. Finally,
NARS2
and
TPT1
in OV,
SMYD2, EGLN1, TNFRSF10D, FUT11, SYTL3, MMP8
and
EREG
in CESC, and
SLC5A1, TXN, KDM4B, TXNDC11,
HSDL2
, COX16, MGAT4A, DAGLA, ELOVL7, THRB
and
PCOLCE2
in UCEC were identified as hub genes in
cancer progression
. Therefore, this study may assist in the identification of novel mechanisms underlying
cancer progression
and new biomarkers for gynecological cancer prognosis and therapy.
...
PMID:Identification of hub genes and key pathways associated with the progression of gynecological cancer. 3178 13